作者：
Jordi,Minguillón [1]
;
María José,Ramírez [2]
;
Llorenç,Rovirosa [1]
;
Pilar,Bustamante-Madrid [2]
;
Cristina,Camps-Fajol [1]
;
Gorka,Ruiz de Garibay [2]
;
Hermela,Shimelis [1]
;
Helena,Montanuy [2]
;
Roser,Pujol [1]
;
Gonzalo,Hernandez [2]
;
Massimo,Bogliolo [3]
;
Pau,Castillo [4]
;
Penny,Soucy [5]
;
Griselda,Martrat [1]
;
Antonio,Gómez [2]
;
Daniel,Cuadras [1]
;
María J,García [2]
;
Javier,Gayarre [1]
;
Cimba [2]
;
Conxi,Lázaro [1]
;
Javier,Benítez [2]
;
Fergus J,Couch [1]
;
Miquel Angel,Pujana [2]
;
Jordi,Surrallés [6]
作者单位：
Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
[1]
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.
[2]
Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.
[3]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, USA.
[4]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901, USA.
[5]
Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC G1E 6W2, Canada.
[6]
Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.
[7]
Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
[8]
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.
[9]
DOI
10.3390/cancers14020353
PMID
35053516
发布时间
2022-12-13
换一批
换一批
